Log In
BCIQ
Print this Print this
 

Actimab-Br

  Manage Alerts
Collapse Summary General Information
Company Actinium Pharmaceuticals Inc.
Description 
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat brain cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today